Respiratory Syncytial Virus (RSV)

Assessing the Real-World Effectiveness of Immunizations for Respiratory Syncytial Virus
 by Fatimah S. Dawood, MD, Amanda B. Payne, PhD, and  Meredith L. McMorrow, MD, MPH  JAMA April 11, 2024

Wastewater Surveillance Predicts Large-Scale Flu, RSV Trends
 by Emily Harris JAMA September 27, 2023

RSV Infection in Older Adults
 by Kathleen A. Linder, MD, and Preeti N. Malani, MD, MSJ JAMA September 7, 2023’

FDA Approves RSV Monoclonal Antibody for Infants and Young Children
 by Emily Harris JAMA July 26, 2023

CDC: RSV Vaccine Recommended for Older People
 by Emily Harris JAMA July 12, 2023

FDA Clears RSV Vaccine for Adults Aged 60 Years or Older
 by Emily Harris JAMA May 17, 2023

RSV Vaccine, Monoclonal Antibody Safe, Effective in Phase 3 Trials
 by Emily Harris JAMA April 13, 2023

RSV virus in babies, children and adults – symptoms and warning signs
 by The Independent. Ie

WATCH: “We are confronting extreme climate events”
 by Alan Rosenbaum The Jerusalem Post

FDA approves RSV injection for infants
 by Aria Bendix NBC News

RSV virus in babies, children and adults – symptoms and warning signs
 by The Independent.ie

Europe approves 1st one-dose drug to protect babies against RSV
 by The Associated Press/PBS

The Worst Pediatric Care Crisis in Decades
 by The Atlantic/Bioethics.com

RSV hospitalizations shoot up to levels typically seen in December, CDC data shows
 by Deidre McPhillip CNN